351 results on '"Demehri, Shadmehr"'
Search Results
52. Lethal Dermal Sarcoma in Immunosuppressed Patients
53. The Absence of a Microbiota Enhances TSLP Expression in Mice with Defective Skin Barrier but Does Not Affect the Severity of their Allergic Inflammation
54. Elevated Epidermal Thymic Stromal Lymphopoietin Levels Establish an Antitumor Environment in the Skin
55. STK11 Loss: A Novel Mechanism for Melanoma Metastasis with Therapeutic Implications
56. Abstract LB003: Combined BRAF, MEK, and PD-1 inhibition in BRAFV600E colorectal cancer patients: Correlative studies from a phase 2 trial
57. CD4+ T helper 2 cells suppress breast cancer by inducing terminal differentiation
58. Thymic Stromal Lymphopoietin Induction Suppresses Lung Cancer Development
59. Alarmin Cytokines as Central Regulators of Cutaneous Immunity
60. Extracellular matrix proteins regulate NK cell function in peripheral tissues
61. Cutaneous Squamous Cell Carcinoma: The Frontier of Cancer Immunoprevention
62. Cytotoxic CD4 + T Cells Eliminate Senescent Cells by Targeting Commensal Cytomegalovirus Antigen
63. Chronic allergic contact dermatitis promotes skin cancer
64. Innate Lymphoid Cells: New Targets for Cutaneous Squamous Cell Carcinoma Immunotherapy
65. Fractional Laser Treatment Boosts Systemic Anti-Tumor Immunity in Combination with OX40 Agonist and PD-1 Blockade
66. Epidermal Notch1 Loss Promotes Skin Tumorigenesis by Impacting the Stromal Microenvironment
67. Desmoglein 4 is regulated by transcription factors implicated in hair shaft differentiation
68. Treatment of an Unresectable Cutaneous Squamous Cell Carcinoma With ED&C and 5-FU.
69. Chronic itch development in sensory neurons requires BRAF signaling pathways
70. Supporting the Next Generation of Scientists to Lead Cancer Immunology Research
71. Cutaneous angiosarcoma of the scalp in a pediatric patient with xeroderma pigmentosum
72. Enhancing the process for care delivery in a dermatology specialty clinic
73. Divergent Roles of Epithelium-Derived Alarmins in Notch Signaling-Deficient Skin
74. Combined PD-1, BRAF and MEK inhibition in BRAFV600Ecolorectal cancer: a phase 2 trial
75. Rejection of benign melanocytic nevi by nevus-resident CD4 + T cells
76. CD8 + T cell immunity blocks the metastasis of carcinogen-exposed breast cancer
77. Meeting Report: Translational Advances in Cancer Prevention Agent Development Meeting
78. Establishment of a murine model of aggressive systemic mastocytosis/mast cell leukemia
79. Hypertrophic Lichen Planus with Histological Features of Squamous Cell Carcinoma Associated with Immune Checkpoint Blockade Therapy
80. A Case of Nivolumab-Induced Cutaneous Toxicity with Multiple Morphologies
81. High-sensitivity detection of BCR-ABL kinase domain mutations in imatinib-naive patients: correlation with clonal cytogenetic evolution but not response to therapy
82. In vitro and in vivo activity of ATP-based kinase inhibitors AP23464 and AP23848 against activation-loop mutants of Kit
83. Effects of MLN518, a dual FLT3 and KIT inhibitor, on normal and malignant hematopoiesis
84. 84 The Role of the GNAS Oncogene in the Immune Microenvironment of Intraductal Papillary Mucinous Neoplasm
85. Bispecific T-Cell Engager -Armored Chimeric Antigen Receptor T Cells Overcome Antigen Escape From EGFRvIII-Targeted Therapy For Glioblastoma
86. Abstract 4948: T helper 2 cells block breast cancer promotion
87. Topical Combination of Fluorouracil and Calcipotriene as a Palliative Therapy for Refractory Extramammary Paget Disease
88. Chimeric antigen receptor costimulation domains modulate human regulatory T cell function
89. Skin cancer precursor immunotherapy for squamous cell carcinoma prevention
90. Immune checkpoint inhibition (ICI) in advanced cutaneous squamous cell carcinoma (cSCC): Clinical response and correlative biomarker analysis.
91. Immunotherapy Directed Against Skin Cancer Precursors Prevents Skin Cancer
92. Fractional Laser Releases Tumor-Associated Antigens in Poorly Immunogenic Tumor and Induces Systemic Immunity
93. Fractional laser exposure induces neutrophil infiltration (N1 phenotype) into the tumor and stimulates systemic anti-tumor immune response
94. A Case of Nivolumab-Induced Cutaneous Toxicity with Multiple Morphologies.
95. Prevention of Skin Cancers With Topical Calcipotriol and Fluorouracil in Patients With Xeroderma Pigmentosum.
96. Randomized trial of calcipotriol combined with 5-fluorouracil for skin cancer precursor immunotherapy
97. Abstract A64: Chronic allergic contact dermatitis, A potent tumor promoter of Marjolin's ulcer
98. Local and Systemic Consequences of Reducing Notch Signaling in Skin Keratinocytes
99. Atopic Dermatitis-Like Disease and Associated Lethal Myeloproliferative Disorder Arise from Loss of Notch Signaling in the Murine Skin
100. Skin-Derived TSLP Triggers Progression from Epidermal-Barrier Defects to Asthma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.